CD8A and neoplasm: In this regard, CD8α+ pDCs activated by TLR7 ligands were shown to exhibit direct tumor-killing activity mediated by granzyme B. Furthermore, TRAIL-expressing pDCs were shown to be capable of cross-presentation [68].